Model 1 | Model 2 | |||
---|---|---|---|---|
HR (95% CI) | P-value | HR (95% CI) | P-value | |
Weight change categories | ||||
Lost > 5% | 1.19 (0.83–1.71) | 0.334 | 1.14 (0.79–1.65) | 0.471 |
Lost 3% to 5% | 0.86 (0.55–1.36) | 0.526 | 0.76 (0.48–1.20) | 0.238 |
Stable (± 3%) | Reference | Reference | ||
Gained 3% to 5% | 0.63 (0.37–1.08) | 0.096 | 0.66 (0.38–1.15) | 0.141 |
Gained > 5% | 0.62 (0.41–0.94) | 0.026 | 0.61 (0.40–0.93) | 0.021 |
Age, year | 1.04 (1.03–1.05) | < 0.001 | 1.04 (1.02–1.05) | < 0.001 |
Women (men as reference) | 0.92 (0.70–1.22) | 0.569 | 0.82 (0.59–1.13) | 0.216 |
BMI, kg/m2 | 0.99 (0.96–1.02) | 0.423 | ||
Educational level, years | ||||
> 12 | Reference | |||
6–12 | 0.91 (0.50–1.66) | 0.768 | ||
< 6 | 0.92 (0.51–1.69) | 0.796 | ||
Current smoker, yes | 1.73 (1.06–2.83) | 0.028 | ||
GLD use, yes | 1.75 (1.27–2.41) | 0.001 | ||
Family history of premature CVD, yes | 1.08 (0.76–1.52) | 0.672 | ||
Hypertension, yes | 1.63 (1.22–2.19) | 0.001 | ||
Hypercholesterolemia, yes | 2.09 (1.43–3.05) | < 0.001 | ||
CKD, yes | 0.76 (0.55–1.05) | 0.099 | ||
FPG, mmol/L | 1.03 (0.99–1.08) | 0.139 |